Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rook

Showing results (51-60 of 187) with videos related to

Pageof 19
Sort By:
Journal of the American Academy of Dermatology|February 9, 2008
Stem cell transplantation in advanced cutaneous T-cell lymphomaCamille E Introcaso, Brian Leber, Kathleen Greene, et al.
Journal of the American Academy of Dermatology|October 5, 2010
A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasisAlain H Rook, Gary S Wood, Madeleine Duvic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4L C Showe, F E Fox, D Williams, et al.
Acta Dermato-Venereologica|March 1, 1997
Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literatureJ M Weinberg, J T Wolfe, S Sood, et al.
Journal of the American Academy of Dermatology|October 19, 2011
Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sézary syndromeArielle R Nagler, Sara Samimi, Andras Schaffer, et al.
Journal of the American Academy of Dermatology|August 23, 2005
Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndromeCamille E Introcaso, Stephen D Hess, Malek Kamoun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Large-cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptorJ T Wolfe, L Chooback, D T Finn, et al.
Lancet (London, England)|July 30, 1983
Treatment of intraocular inflammatory disease with cyclosporin AR B Nussenblatt, A G Palestine, A H Rook, et al.
Archives of Dermatology|August 18, 2010
Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppressionSara Samimi, Bernice Benoit, Katherine Evans, et al.
Blood|December 1, 1995
The clonal nature of circulating Sezary cellsJ M Weinberg, C Jaworsky, B M Benoit, et al.
Pageof 19

Showing results (51-60 of 187) with videos related to

Sort By:
Pageof 19
Journal of the American Academy of Dermatology|February 9, 2008
Stem cell transplantation in advanced cutaneous T-cell lymphomaCamille E Introcaso, Brian Leber, Kathleen Greene, et al.
Journal of the American Academy of Dermatology|October 5, 2010
A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasisAlain H Rook, Gary S Wood, Madeleine Duvic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4L C Showe, F E Fox, D Williams, et al.
Acta Dermato-Venereologica|March 1, 1997
Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literatureJ M Weinberg, J T Wolfe, S Sood, et al.
Journal of the American Academy of Dermatology|October 19, 2011
Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sézary syndromeArielle R Nagler, Sara Samimi, Andras Schaffer, et al.
Journal of the American Academy of Dermatology|August 23, 2005
Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndromeCamille E Introcaso, Stephen D Hess, Malek Kamoun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Large-cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptorJ T Wolfe, L Chooback, D T Finn, et al.
Lancet (London, England)|July 30, 1983
Treatment of intraocular inflammatory disease with cyclosporin AR B Nussenblatt, A G Palestine, A H Rook, et al.
Archives of Dermatology|August 18, 2010
Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppressionSara Samimi, Bernice Benoit, Katherine Evans, et al.
Blood|December 1, 1995
The clonal nature of circulating Sezary cellsJ M Weinberg, C Jaworsky, B M Benoit, et al.
Pageof 19